Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$172.34M
↑ 256% above average
Average (9y)
$48.43M
Historical baseline
Range
High:$172.34M
Low:$-8.62M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $172.34M | +18.6% |
| 2023 | $145.34M | +123.1% |
| 2022 | $65.15M | -7.6% |
| 2021 | $70.54M | +201.3% |
| 2020 | $23.41M | +11209.7% |
| 2019 | $207000.00 | +102.4% |
| 2018 | $-8.62M | -309.7% |
| 2017 | $4.11M | -76.1% |
| 2016 | $17.18M | +420.1% |
| 2015 | $-5.37M | - |